SCHEMBL13259016

SCHEMBL13259016

CC1Oc2ccc(Cc3nnc(SCc4ccc(F)cc4Cl)n3-c3ccc(F)cc3Cl)cc2O1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.42
RAB9A P51151 2/20 0.42
KDM4E B2RXH2 1/20 0.42
NPC1 O15118 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP2C19 P33261 1/20 0.37
RXFP1 Q9HBX9 1/20 0.37
GPBAR1 Q8TDU6 1/20 0.37
TLR8 Q9NR97 3/20 0.37
L3MBTL1 Q9Y468 1/20 0.36
TP53 P04637 3/20 0.36
NPSR1 Q6W5P4 2/20 0.35
HTT P42858 1/20 0.35
RECQL P46063 1/20 0.35
ALOX15 P16050 1/20 0.35
CRHBP P24387 1/20 0.35
CRHR2 Q13324 1/20 0.35
HSD17B10 Q99714 1/20 0.35
LMNA P02545 2/20 0.34
MAPT P10636 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13259977 0.91 GPBAR1 (0.47) SMN1; SMN2RAB9AKDM4ENPC1CYP1A2
SCHEMBL13259978 0.87 GPBAR1 (0.41) SMN1; SMN2RAB9AKDM4ENPC1CYP1A2
SCHEMBL13259961 0.82 GPBAR1 (0.47) SMN1; SMN2RAB9ANPC1GPBAR1HTT
SCHEMBL10229727 0.81 GPBAR1 (0.58) SMN1; SMN2RAB9AKDM4ENPC1CYP1A2
SCHEMBL10229673 0.77 HTT (0.48) SMN1; SMN2RAB9AKDM4ENPC1GPBAR1
SCHEMBL13259966 0.77 GPBAR1 (0.59) SMN1; SMN2GPBAR1NPSR1HTTRECQL
SCHEMBL13259015 0.76 GPBAR1 (0.46) SMN1; SMN2GPBAR1TLR8L3MBTL1TP53
SCHEMBL13259012 0.76 HTR2C (0.36) RAB9AGPBAR1L3MBTL1LMNA
SCHEMBL13259018 0.75 GPBAR1 (0.67) SMN1; SMN2GPBAR1TP53NPSR1HTT
SCHEMBL10229731 0.74 GPBAR1 (0.51) SMN1; SMN2RAB9AKDM4ENPC1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010093845-A1 TRIAZOLE AND IMIDAZOLE DERIVATIVES FOR USE AS TGR5 AGONISTS IN THE TREATMENT OF DIABETES AND OBESITY EXELIXIS, INC. (US) 2010-08-19 WO disclosed